Anticancer efficacies of persicogenin and homoeriodictyol isolated from Rhus retinorrhoea
Quaiser Saquib,Sarfaraz Ahmed,Mohammad S. Ahmad,Adnan J. Al-Rehaily,Maqsood A. Siddiqui,Mohammad Faisal,Javed Ahmad,Asma N. Alsaleh,Abdulrahman A. Alatar,Abdulaziz A. Al-Khedhairy
DOI: https://doi.org/10.1016/j.procbio.2020.02.008
IF: 4.885
2020-08-01
Process Biochemistry
Abstract:Herein we examined two flavanones (persicogenin and homoeriodictyol) isolated from Rhus retinorrhoea to elucidate the mechanism of their anti-cancer effects in MCF-7, HeLa, and HT-29 cells. Based on the [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)] (MTT) cytotoxicity data of persicogenin (500 μg/ml) caused a 58.1% reduction in HT-29 survival while homoeriodictyol (500 μg/ml) caused a 51.9%, 66.7% and 76.2% reduction in MCF-7, HeLa and HT-29 cell survival, respectively. The neutral red uptake (NRU) assay revealed 53.6%, 53.9%, 58.8% and 83.0%, 87.7%, 66.7% reductions in MCF-7, HeLa, and HT-29 cell survival following persicogenin and homoeriodictyol (500 μg/ml) treatment, respectively. Moreover, the intracellular reactive oxygen species (ROS) was significantly enhanced and dysfunction of mitochondrial membrane potential (ΔΨm) confirmed the mitochondrial injury in all cell types by the flavanones. MCF-7, HeLa, and HT-29 cells exposed to persicogenin and homoeriodictyol (500 μg/ml) had showed 42.5%, 63.1%, 62.3% and 30.7%, 30.2%, 23.8% cells in the sub G1 apoptotic phase. The persicogenin- and homoeriodictyol-treated cell lines had upregulated expression of p53, caspase-3, caspase-9, bax, and superoxide dismutase 1 (SOD1) genes. Such findings provide novel insight into the comparative anti-cancer efficacy of persicogenin and homoeriodictyol, signifying their promising clinical applications as cancer treatments and their application as bioactive therapeutic agents.
biochemistry & molecular biology,biotechnology & applied microbiology,engineering, chemical